Skip to main content
Caplight Logo









Synfini

Synfini

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://synfini.com/

Last Round

VC Round

Jul 7, 2025

Total Funding Raised

$41M

Company Overview

Synfini is a biotechnology company that offers an AI-driven drug discovery platform aimed at accelerating the design, development, and synthesis of new therapeutics through the use of integrated neuro-symbolic AI, robotic automation, and comprehensive chemistry data.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Industrial Robotics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Government Contracts

AI Layer

Infrastructure

Keywords

drug discovery platformsmall molecule discoveryai drug discoveryrobotic laboratory automationneuro-symbolic airetrosynthetic planningdmta cyclelab automationautomated chemistryin silico drug designcloud foundrychemist-in-the-looppreclinical developmenthigh-throughput experimentationai biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synfini Comparables

Compare Synfini with similar companies based on industry and business-model similarity.

Synfini comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Iktos
81%
Chemical.AI
81%
Excelsior Sciences
80%

Synfini Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 7, 2025
GrantSep 26, 2023
SeedSep 26, 2023

Synfini Investors

Notable investors and investment history

Synfini investors
InvestorRounds
GaingelsVC Round
JSL Health CapitalVC Round
Foothill VenturesVC Round
High Water Venture PartnersVC Round
SRI VenturesVC Round, Seed
Ferocity CapitalVC Round
WERU Investment Co.VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Launched Fast Pass I, an open, rapid cloud workflow system.

  • Oct 23, 2025

    Selected for the Innovation AveNEW showcase at SLAS 2026.

Synfini Filings

Explore SEC and related filing metadata, where available.

Synfini filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Synfini's valuation, stock price, and market status.

Is Synfini a public or private company?

Synfini is a private company.

What is the current stock price of Synfini?

Synfini is a private company with no public stock price. No recent secondary market data is available.

How much is Synfini worth (valuation)?

Valuation information for Synfini is not publicly available.

Can I buy Synfini stock?

Synfini shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Synfini's last funding round?

Synfini's most recent funding round was Seed on July 7, 2025.

Who are the main investors in Synfini?

Key investors in Synfini include JSL Health Capital.

Will Synfini IPO soon?

No public IPO plans have been announced for Synfini.

How can I track Synfini secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synfini's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range9
Year Founded2023
Last FundingJul 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?